Contract 75F40123C00192
Akina, Inc. · Department Of Health And Human Services · August 23, 2024
Akina, Inc. was awarded a federal contract by Department Of Health And Human Services (Food And Drug Administration) on August 23, 2024 for $556,000 of work in research and development in biotechnology (except nanobiotechnology). Performance is in West Lafayette, IN. It was awarded under full and open competition. The contract has been modified 2 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on December 22, 2025. If all options are exercised, the contract could reach $1.21 million.
Contract details
- PIID
- 75F40123C00192
- Award type
- Definitive Contract
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Special Studies/Analysis- Chemical/Biological
- Place of performance
- West Lafayette, IN
- First action
- August 23, 2024
- Latest action
- December 22, 2025
Description
NEW PLGA ANALYTICAL METHODS FOR MINI-SIZE COMPLEX LONG-ACTING INJECTABLE FORMULATIONS
Modification timeline
-
December 22, 2025Mod P00003 · Exercise An Option$1.21M
-
July 16, 2025Mod P00002 · Other Administrative ActionNO COST MODIFICATION TO CHANGE THE PERIOD OF PERFORMANCE END DATE TO DECEMBER 31, 2025.$927.9K
-
August 23, 2024Mod P00001 · Exercise An OptionTHIS IS A FIRM FIXED PRICE FORNEW PLGA ANALYTICAL METHODS FOR MINI-SIZE COMPLEX LONG-ACTING INJECTABLE FORMULATIONS.$927.9K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Vericel Corporation | Department Of Health And Human Services | April 1, 2026 | $34.88M |
| American College Of Medical Toxicology, Inc. | Department Of Health And Human Services | March 31, 2026 | $0 |
| Ceramedix Holding, Llc | Department Of Health And Human Services | March 31, 2026 | $4.22M |
| Glaxosmithkline, Llc | Department Of Health And Human Services | March 31, 2026 | $7.79M |
| Care Access Research Llc | Department Of Health And Human Services | March 31, 2026 | $2.55M |
| Pattern Bioscience, Inc. | Department Of Health And Human Services | March 31, 2026 | $22.50M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Amgen USA Inc | 1 | $59.99M |
| 2 | Vericel Corporation | 1 | $34.88M |
| 3 | Spectral Md, Inc. | 1 | $31.67M |
| 4 | Ppd Development Lp | 6 | $31.12M |
| 5 | L3 Technologies, Inc. | 1 | $22.00M |
| 6 | Technical Resources International, Inc. | 6 | $21.80M |
| 7 | Abbott Laboratories | 1 | $21.01M |
| 8 | Paratek Pharmaceuticals, Inc | 1 | $17.47M |
| 9 | Ossium Health, Inc. | 1 | $12.39M |
| 10 | Rho Federal Systems Division Inc | 1 | $8.00M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75F40123C00192?
Contract 75F40123C00192 is a federal contract awarded to Akina, Inc. by Department Of Health And Human Services on August 23, 2024 for $556,000 of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 2 times since the base award.
Who won contract 75F40123C00192?
Akina, Inc. won contract 75F40123C00192 from Department Of Health And Human Services.
How much is contract 75F40123C00192 worth?
Contract 75F40123C00192 has obligated $556,000 to date, with a total potential value of $1.21 million if all options are exercised.